Your browser doesn't support javascript.
loading
Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in Health Care Workers: A Prospective Longitudinal Study.
Kim, Jung-Ah; Bang, Hae In; Shin, Jeong Won; Park, Yoonhye; Kim, Saerom; Kim, Mi-Young; Jang, Eui Young; Shin, Woo Yong; Kim, Jieun; Park, Rojin; Choi, Tae Youn.
Afiliação
  • Kim JA; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Bang HI; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Shin JW; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Park Y; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Kim S; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Kim MY; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Jang EY; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Shin WY; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Kim J; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Park R; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
  • Choi TY; Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
Ann Lab Med ; 42(6): 688-692, 2022 Nov 01.
Article em En | MEDLINE | ID: mdl-35765878

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Lab Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Lab Med Ano de publicação: 2022 Tipo de documento: Article